Literature DB >> 7698832

Pharmacokinetic and pharmacodynamic models of antimicrobial drugs in vitro and in vivo.

H Mattie.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7698832     DOI： 10.1007/bf01715491

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  14 in total

1.  Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics.

Authors:  H Mattie; A M van Dokkum; L Brus-Weijer; A M Krul; E van Strijen
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

2.  Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.

Authors:  B Vogelman; S Gudmundsson; J Leggett; J Turnidge; S Ebert; W A Craig
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

Review 3.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

4.  Effectiveness of netilmicin and tobramycin against Pseudomonas aeruginosa in vitro and in an experimental tissue infection in mice.

Authors:  B G Moffie; J J Hoogeterp; T Lim; A E Douwes-Idema; H Mattie
Journal:  J Antimicrob Chemother       Date:  1993-03       Impact factor: 5.790

5.  Activity of erythromycin and clindamycin in an experimental Staphylococcus aureus infection in normal and granulocytopenic mice. A comparative in vivo and in vitro study.

Authors:  J J Hoogeterp; H Mattie; R van Furth
Journal:  Scand J Infect Dis       Date:  1993

6.  Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins.

Authors:  N Frimodt-Møller; M W Bentzon; V F Thomsen
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

7.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

8.  The pneumococcus and the mouse-protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin.

Authors:  N Frimodt-Møller; V F Thomsen
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-06

9.  Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics.

Authors:  A U Gerber; H P Brugger; C Feller; T Stritzko; B Stalder
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

10.  Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo.

Authors:  H Mattie; B A Sekh; M L van Ogtrop; E van Strijen
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.